| Dr Nataly Monserrath Vasquez Encalada, MD | |
|
6161 S Yale Ave, Tulsa, OK 74136 | |
| (918) 502-1900 | |
| (918) 494-6303 |
| Full Name | Dr Nataly Monserrath Vasquez Encalada |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 16 Years |
| Location | 6161 S Yale Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992083851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 32614 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peacehealth St John Medical Center | Longview, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 5890689293 | 182 |
News Archive
A new study has found that adolescents suffering from bipolar disorder are more likely to develop substance use disorders if they have lower gray matter volume in the brain, a clue that can help in the design of better methods for early detection and more targeted prevention and treatment.
NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration of its Investigational Device Exemption application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy.
A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration. The discovery creates a potential new target for developing treatments of diseases like Parkinson's and Alzheimer's.
Many orthopedic surgeons are debating whether Warsaw, Ind.-based Zimmer Holdings' knee implant Gender Solutions, which is designed specifically for women, is better for women than the standard artificial knee, Reuters reports.
Researchers at Boston University School of Medicine (BUSM) have found that some medical inpatients with unhealthy alcohol use may benefit from a brief intervention.
› Verified 2 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
A new study has found that adolescents suffering from bipolar disorder are more likely to develop substance use disorders if they have lower gray matter volume in the brain, a clue that can help in the design of better methods for early detection and more targeted prevention and treatment.
NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration of its Investigational Device Exemption application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy.
A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration. The discovery creates a potential new target for developing treatments of diseases like Parkinson's and Alzheimer's.
Many orthopedic surgeons are debating whether Warsaw, Ind.-based Zimmer Holdings' knee implant Gender Solutions, which is designed specifically for women, is better for women than the standard artificial knee, Reuters reports.
Researchers at Boston University School of Medicine (BUSM) have found that some medical inpatients with unhealthy alcohol use may benefit from a brief intervention.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nataly Monserrath Vasquez Encalada, MD 6600 S Yale Ave Ste 1200, Tulsa, OK 74136-3361 Ph: (918) 488-6045 | Dr Nataly Monserrath Vasquez Encalada, MD 6161 S Yale Ave, Tulsa, OK 74136 Ph: (918) 502-1900 |
News Archive
A new study has found that adolescents suffering from bipolar disorder are more likely to develop substance use disorders if they have lower gray matter volume in the brain, a clue that can help in the design of better methods for early detection and more targeted prevention and treatment.
NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration of its Investigational Device Exemption application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy.
A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration. The discovery creates a potential new target for developing treatments of diseases like Parkinson's and Alzheimer's.
Many orthopedic surgeons are debating whether Warsaw, Ind.-based Zimmer Holdings' knee implant Gender Solutions, which is designed specifically for women, is better for women than the standard artificial knee, Reuters reports.
Researchers at Boston University School of Medicine (BUSM) have found that some medical inpatients with unhealthy alcohol use may benefit from a brief intervention.
› Verified 2 days ago
Sarah Anne Shaw-dressler, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave Ste 100a, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Julia Margaret Kwon, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1705 E 19th St Ste 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Peter Madden, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4502 E 41st St, Tulsa, OK 74135 Phone: 918-619-4400 | |
Thao Tran, D.O Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4502 E. 41st Street, Tulsa, OK 74135 Phone: 918-619-4400 | |
Robert Peter Aran, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6160 S Yale Ave Ste 100, Tulsa, OK 74136 Phone: 918-497-3300 Fax: 918-497-3365 | |
Robert Dean Okada, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6151 S Yale Ave, Ste 304, Tulsa, OK 74136 Phone: 918-494-5300 Fax: 918-494-5455 | |
Dr. Charles Wade Taylor, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 Fax: 918-505-3253 |